The Impact of Artificial Intelligence on Diagnostic Medicine

Abstract

This review explores the integration of artificial intelligence (AI) in diagnostic medicine, highlighting its transformative impact on various medical specialties, including radiology, pathology, and patient data management. AI significantly enhances diagnostic accuracy, automates routine tasks, and optimizes healthcare resources, facilitating a shift towards more personalized and preventive medicine. It enables advanced capabilities in medical imaging and predictive diagnostics, improving early disease detection and patient care management. Furthermore, AI’s integration in diagnostic medicine is reshaping economic and global healthcare landscapes by reducing costs, enhancing service accessibility, and driving substantial market growth. These advancements extend AI’s benefits across geographical boundaries, democratizing healthcare and standardizing care across diverse healthcare systems, thereby promising to transform the economic landscape of global health services. Despite its benefits, the integration of AI into mainstream medical practice faces challenges, including ethical concerns about data privacy and the potential biases of algorithms. Addressing these issues requires robust ethical guidelines, transparent practices, and collaborative efforts among stakeholders in technology and medicine. The evolution of AI promises substantial advancements in healthcare efficiency and patient outcomes, contingent on successfully overcoming these technical and practical hurdles.

Introduction

Artificial intelligence (AI) in diagnostic medicine encapsulates a rapidly advancing frontier that integrates sophisticated algorithms and machine learning technologies to enhance diagnostic accuracy and efficiency. As these technologies evolve, they are increasingly playing a pivotal role in various diagnostic applications, from image analysis in radiology1 to predictive diagnostics that foresee disease progression,2 and comprehensive management of patient data.3 This review article explores the transformative impact of AI across medical specialties, including radiology, pathology, and patient data management. It highlights how AI both refines diagnostic processes and enables earlier disease intervention and more personalized patient care strategies. Moreover, this article examines the economic and global impacts of AI in diagnostic medicine, highlighting how AI is driving cost reductions, market growth, and the ­standardization of healthcare services internationally, which enhance healthcare accessibility and efficiency and have profound implications for the economic dynamics of the healthcare industry.

By exploring significant advancements and applications, this article aims to provide insights into how AI is reshaping diagnostic practices and what this means for future healthcare delivery. Additionally, it addresses crucial ethical considerations such as data privacy and algorithmic biases, emphasizing the need for balanced discourse on AI’s potential and challenges. This narrative sets the stage for a comprehensive discussion on integrating AI innovations responsibly into mainstream medical practice, promising to transform the landscape of diagnostic medicine.

Current Applications of AI in Diagnostic Medicine

AI in Medical Imaging

The integration of AI in medical imaging has significantly transformed diagnostic processes, particularly in radiology, pathology, and dermatology. Advanced AI algorithms, notably deep learning models, have been pivotal in enhancing image analysis across these fields. In radiology, AI has been effectively applied to streamline complex diagnostic workflows,4–6 reduce radiologist fatigue,7 and improve the accuracy of image interpretations.8 For instance, AI-driven techniques in mammography and MRI have significantly enhanced the detection and diagnosis of breast cancer9,10 and neurological disorders.11,12

In pathology, AI models help in the automated analysis of tissue samples, assisting pathologists in identifying disease markers more swiftly and with greater precision. This application has proven vital in expediting diagnosis and ensuring more reliable disease monitoring.13,14 Additionally, AI-driven tools in pathology can quantify features that are often challenging for human observers to assess consistently, such as the degree of tumor infiltration15,16 or the density of immune cells within a sample.17 These capabilities enhance the accuracy of diagnoses as well as provide valuable prognostic information that can guide treatment decisions. Moreover, by integrating AI with digital pathology, labs can handle larger volumes of samples more efficiently, reducing wait times and potentially improving patient outcomes through quicker therapeutic interventions.14,18

Furthermore, dermatology has seen AI-driven advancements in the analysis of skin lesion images, aiding in the early detection of skin cancers such as melanoma, where AI algorithms assist in distinguishing between benign and malignant lesions with a high degree of accuracy.19,20 This precision is ­critical in reducing unnecessary biopsies and ensuring timely treatment for malignant cases. Additionally, AI applications in dermatology extend to tracking lesion changes over time, offering dermatologists a dynamic tool to monitor patient conditions and response to treatment.21 These AI systems can also integrate with dermatological databases to provide comparative analyses, further enhancing diagnostic accuracy by referencing a vast array of documented cases.22,23

The emergence of convolutional neural networks (CNNs) and other advanced AI frameworks has enabled these technologies to learn and identify complex patterns within imaging data, which surpasses traditional methods in speed and accuracy.24 This capability is crucial for early disease detection and personalized treatment planning, thereby significantly influencing patient outcomes.24 Additionally, these AI tools facilitate the automation of routine tasks, allowing medical professionals to focus more on patient care rather than the technical aspects of diagnosis.25 By automating image segmentation and enhancing the visualization of medical scans, AI contributes to a more comprehensive understanding of complex medical conditions, thereby aiding in more effective treatment strategies.26

Predictive Diagnostics

AI has notably enhanced the capabilities of predictive diagnostics in healthcare, significantly impacting preventive medicine strategies. AI models have been effectively used to predict disease progression and diagnosis, thus facilitating early intervention and improving patient management.2,27 For example, AI systems utilizing machine learning algorithms have demonstrated proficiency in forecasting patient outcomes and potential disease risks based on historical data and ongoing patient monitoring.28,29 The use of AI in predictive diagnostics extends to chronic disease management, where AI algorithms predict exacerbations and complications before they manifest severely, allowing for timely and targeted treatment.30,31 This is particularly beneficial in conditions like diabetes31,32 and cardiovascular diseases,30,33,34 where early detection of potential complications can substantially alter the treatment approach and patient prognosis. Moreover, AI tools can continuously monitor patient data to identify subtle changes that may indicate worsening conditions, enabling interventions before acute episodes occur.2 This proactive approach improves patient outcomes and reduces the overall burden on healthcare systems by preventing costly emergency interventions and hospitalizations.

Moreover, AI-driven predictive analytics supports personalized medicine by analyzing vast datasets to identify subtle patterns that may not be evident to human observers. This capability enables healthcare providers to tailor treatment plans that are optimally effective for individual patients based on their specific genetic makeup and disease manifestations.35,36 AI models are transforming how diseases are predicted and managed and revolutionizing the operational aspects of healthcare systems by enhancing the efficiency of care delivery and reducing unnecessary healthcare utilization.37–39

Patient Data Management

The integration of AI into patient data management is revolutionizing healthcare by enhancing the handling, analysis, and security of large-scale patient data sets.40 AI technologies facilitate the aggregation and analysis of vast amounts of health data, enabling healthcare providers to make more informed decisions, improve treatment outcomes, and optimize health services.27,40 Additionally, AI tools are crucial in enhancing the interoperability between different health systems, ensuring that patient data flows seamlessly across various platforms without compromising privacy or security.41 These advancements streamline clinical workflows and significantly reduce the time clinicians spend on administrative tasks, allowing more focus on direct patient care.42 Moreover, AI contributes significantly to the improvement of data accuracy and accessibility in healthcare. Through advanced algorithms, AI systems can identify and correct errors in real-time, ensure data consistency across platforms, and provide healthcare professionals with easy access to patient histories, diagnostic information, and treatment outcomes.43 This level of accuracy and accessibility supports better clinical decisions and enhances patient care.27

Economic and Global Impacts of AI

AI in diagnostic medicine is reshaping economic and global healthcare landscapes by reducing costs, driving market growth, enhancing medical service accessibility in underresourced regions, and standardizing care across diverse healthcare systems worldwide. Through these advancements, AI optimizes economic efficiency in healthcare delivery and extends its benefits across geographical boundaries, democratizing and transforming global health services.

Economic Impacts

Healthcare Savings

The integration of AI in diagnostic medicine is significantly reducing healthcare costs by minimizing the necessity for repeat tests, decreasing misdiagnosis rates, and enhancing resource allocation. Studies show that AI can reduce the rates of diagnostic errors by up to 50%, which directly lowers the need for subsequent testing and associated costs.8 Further, AI applications in imaging and diagnostics have demonstrated a reduction in unnecessary procedures, significantly enhancing the cost-effectiveness of patient management.44 AI also streamlines workflow in medical facilities, automating tasks such as data entry, billing, coding, and claims processing, which historically consume substantial clinician time. This optimization of tasks significantly lowers labor costs and improves service delivery in healthcare settings. By reducing the human hours required for these processes, AI implementations enhance overall efficiency and reduce expenditure on workforce deployment in healthcare facilities.37

Additionally, AI-driven tools in diagnostic medicine aid in early disease detection and monitoring, significantly enhancing the management of chronic diseases. This proactive approach helps in reducing the frequency and severity of exacerbations and lowers overall healthcare costs by mitigating the need for acute emergency interventions and lengthy hospital stays. Such improvements in patient monitoring and disease management have been shown to enhance patient outcomes and reduce long-term healthcare expenditures.45

The economic impact of AI is also evident in its ability to enhance the precision of diagnostic tests, particularly for patients with rare diseases. By improving the accuracy of initial diagnostics, AI systems significantly reduce the costs associated with misdiagnoses and unnecessary subsequent treatments.46 The implementation of second-generation AI-based systems, as detailed by Hurvitz et al., facilitates early and accurate disease identification, thereby decreasing the frequency of costly, advanced treatments typically necessitated by delayed or incorrect diagnosis.46 This targeted approach in diagnostics, especially for rare conditions, can lead to substantial cost savings within healthcare systems.46 These findings underscore the substantial economic advantages of implementing AI in diagnostic medicine, supporting a shift towards more AI-integrated healthcare processes that promise to reshape the economic landscape of healthcare delivery.

Market Growth

The market for AI in diagnostic medicine has witnessed exponential growth, driven by increased demand for precision diagnostics and efficiency in healthcare delivery. Forecasts predict the global AI in healthcare market size, valued at USD 20.9 billion in 2024, to reach USD 148.4 billion by 2029, growing at a compound annual growth rate (CAGR) of 48.1% during the forecast period from 2024 to 2029.47 This significant growth is driven by the generation of large and complex healthcare datasets, the pressing need to reduce healthcare costs, improving computing power and declining hardware costs, and the rising number of partnerships and collaborations among different domains in the healthcare sector.47 Figure 1 provides a visual representation of the global AI in healthcare market’s projected growth, highlighting the regional distribution of market values from 2024 to 2029.

In emerging markets, AI is poised to play a critical role in transforming healthcare systems. As these regions face growing demands for healthcare services alongside expanding technological infrastructure, AI offers a promising solution to enhance healthcare delivery and efficiency. The rapid adoption of AI in these markets is facilitated by more flexible regulatory environments and the urgent need to address significant shortages in medical expertise and facilities.48 Particularly, the Asia-Pacific region is experiencing rapid growth in AI integration within healthcare sectors, driven by fast-paced urbanization and digitalization in major economies such as China and India.48

The expansion of AI in these markets is also fueled by government initiatives and investments in digital health. For example, India’s government has significantly increased funding for health informatics, including AI, as part of its National Health Policy.49 Similarly, China has included AI healthcare solutions in its Five-Year Plan, aiming to cement its position as a leader in this transformative technology.50 This significant market expansion is expected to impact global healthcare by both increasing accessibility and making healthcare delivery more cost-effective and standardized across different regions. The economic implications of AI extend beyond direct healthcare cost savings, influencing broader economic dynamics such as employment, technology development sectors, and public health outcomes.51

Global Impacts

Accessibility Improvements

AI significantly enhances the accessibility of medical diagnostics in under-resourced regions, democratizing healthcare by providing high-quality diagnostics to remote and underserved communities. Mobile health technologies, powered by AI, play a crucial role in these advancements. For example, portable AI-driven diagnostic devices allow for rapid disease screening and real-time data analysis, bypassing the need for extensive medical infrastructure.52 In rural areas of sub-Saharan Africa, AI-powered mobile tools have been deployed to detect and diagnose infectious diseases such as tuberculosis and HIV more efficiently than traditional methods.53 These tools use machine learning algorithms to analyze images or diagnostic tests quickly, providing immediate results to healthcare providers and patients in areas where medical labs and specialists are scarce.53

Similarly, in remote regions of Asia and the Western Pacific, digital health technologies have significantly enhanced the management of cardiometabolic diseases. AI and other digital tools have been integrated into health systems to support the prevention, diagnosis, and management of these diseases. These innovations allow health workers to monitor patients remotely, utilizing mobile apps and wearable gadgets to track patient data, predict health deterioration, and facilitate timely interventions by medical staff.54 Such applications improve patient outcomes by enabling early prevention and better management of chronic diseases and reducing the necessity for frequent travel to healthcare facilities, a critical benefit for rural populations where such travel is both costly and logistically challenging.54

Furthermore, AI-enhanced mobile applications are used in South America to track the spread of vector-borne diseases like dengue fever, enabling quicker and more precise responses to outbreaks in isolated communities.55 These technologies, including the application of citizen science and AI, help gather and analyze epidemiological data in real time, significantly improving the speed and accuracy of public health interventions.56 The proliferation of AI in these contexts illustrates its potential to break down traditional barriers to medical services, ensuring that all global citizens can access the care they need, regardless of their geographic location.

Standardization of Care

AI is playing a pivotal role in standardizing diagnostic procedures across various countries and healthcare systems, ensuring that all patients receive consistent and high-quality care, irrespective of their geographic location. AI algorithms, particularly in diagnostic imaging, are instrumental in offering uniform analysis, which significantly reduces variability that can arise from human interpretation.57 Globally, AI-driven diagnostic tools are being integrated into clinical practice to ensure adherence to international best practices. For instance, AI systems in radiology interpret imaging results with high accuracy and follow globally recognized guidelines, enabling consistent diagnoses across different regions.4 These tools are particularly beneficial in areas with a shortage of specialists, as they provide decision support to less experienced clinicians, thus elevating the standard of care.58

Moreover, AI applications are harmonizing the treatment protocols in chronic disease management by analyzing vast amounts of data to recommend the most effective treatment plans. This aligns with the best practices and also personalizes care in a standardized manner, ensuring patients in different parts of the world receive equally effective treatments.31 In cardiovascular care, AI algorithms help standardize the assessment of echocardiograms, often ­outperforming general practitioners and matching the accuracy of subspecialists.59 The standardization extends to the speed of healthcare delivery. AI tools automate routine diagnostic tasks, reducing the time from diagnosis to treatment initiation. This standardization of timelines is critical in acute medical conditions, such as stroke, where rapid response is crucial and now achievable globally through AI integration.60 Through these mechanisms, AI is crucial in enhancing the quality of healthcare and ensuring that such quality is universally accessible, thus contributing to global health equity.

Ethical Implications of AI in Medicine

Data Privacy and Security Challenges

The implementation of AI in medicine raises significant ethical concerns related to data privacy and security. As healthcare systems increasingly rely on AI for data processing and decision-making, the risk of breaches and unauthorized data access escalates. AI technologies implement robust security measures to protect sensitive patient information against unauthorized access and cyber threats.61,62 These systems are designed to comply with regulatory standards such as HIPAA in the U.S., ensuring that patient data is handled securely and with the utmost privacy.61 However, the dynamic nature of AI necessitates continuous adaptation of these policies to address emerging threats effectively. Additionally, the integration of AI into healthcare requires the development of new standards that specifically address the nuances of machine learning and data analytics to maintain patient confidentiality.63 Ensuring that AI systems comply with these evolving standards is critical for building trust and ensuring the safe use of technology in sensitive environments.64

Bias in AI Algorithms and Misdiagnosis Risks

Bias in AI algorithms is a critical ethical issue, particularly because it can lead to misdiagnosis and unequal healthcare outcomes.65,66 AI systems trained on data that lack diversity can develop biases that disadvantage certain patient groups.67,68 This is especially problematic in diagnostics, where biased algorithms could misinterpret symptoms based on skewed datasets.69 Efforts to mitigate these biases must include diverse training datasets and ongoing scrutiny of AI decisions against real-world outcomes.70,71 Moreover, healthcare providers must be trained to understand and identify potential biases in AI tools, ensuring that they remain critical of AI-supported conclusions.67,72,73 Transparency in AI development processes and the criteria used for dataset selection are essential to foster trust and reliability in AI diagnostics.

Patient Trust and Informed Consent

Gaining patient trust and managing informed consent in an AI-driven healthcare environment is complex. Patients must be adequately informed about how their data will be used, the role of AI in their care, and what to expect in terms of outcomes.74,75 Transparent communication and ethical considerations must be prioritized to ensure that patients feel secure in the knowledge that their data is handled responsibly and that AI tools are used in their best interest.66,76 This involves clear disclosures about the AI systems’ capabilities and limitations and assurances that patient autonomy is respected in all AI interactions.75 Ensuring this level of transparency and ethical consideration helps build trust and facilitates better patient engagement with AI-integrated health systems.

Accuracy and Reliability of AI Diagnostics

Evaluating the Current Accuracy Levels of AI Diagnostics

AI has demonstrated high accuracy in various diagnostic tasks, particularly in fields like radiology77 and ophthalmology.78 Studies show that AI systems can match or even surpass human experts in tasks such as detecting diabetic retinopathy and other retinal diseases with a high degree of precision.79,80 The accuracy of AI in these areas is often enhanced by the ability to learn from vast datasets, which enables the detection of subtle patterns that may be missed by human observers.81 This proficiency allows for quicker diagnostics and potentially earlier intervention, which is crucial in conditions where time is of the essence for treatment efficacy.

Comparing AI Performance to Human Diagnostics

When compared to human diagnostics, AI has shown equivalent or superior performance in several diagnostic tests. For example, AI’s ability to analyze large-scale image data can lead to more consistent and timely diagnoses than those made by human specialists, who may vary in their interpretations based on experience and subjective judgment.82,83 Furthermore, AI tools are not susceptible to fatigue, which can affect human performance, thereby offering a potential for greater diagnostic consistency and reliability.69 This enhanced reliability is particularly significant in high-stress environments like emergency rooms, where rapid and accurate decisions are crucial.65 Additionally, AI systems can integrate and analyze data from multiple sources simultaneously, something that is more challenging for humans, thus providing a more holistic approach to diagnostics.

Factors Influencing Reliability and Error Rates

The reliability and accuracy of AI diagnostics hinge on several factors. Firstly, the quality of the training data plays a crucial role; if the data is poor or lacks diversity, AI models may not perform effectively across different patient populations, leading to skewed outcomes and potential misdiagnoses.66 Additionally, biases inherent in the data can cause AI systems to perpetuate these biases unless explicitly corrected.81,84 Moreover, the thoroughness of the validation processes ­determines how well these systems generalize beyond their ­training environments to real-world settings, where they must handle data variations and complexities they were not explicitly trained on.85 To enhance reliability and reduce error rates in AI diagnostics, a multi-faceted approach is necessary. Improving data quality by ensuring it is comprehensive and representative of varied demographics can mitigate bias and enhance model accuracy.14,86 Rigorous and continuous validation of AI models against new and diverse datasets ensures these systems remain effective and adaptable to evolving medical landscapes.26 These efforts collectively contribute to more dependable AI applications in healthcare, promoting better patient outcomes and trust in new technologies.

The Future of AI in Diagnostic Medicine

Potential Advancements in AI Technology

The future of AI in diagnostic medicine is poised for significant technological advancements. As AI continues to evolve, it is expected to further enhance diagnostic precision across various medical specialties. With developments in machine learning and deep learning, AI is set to improve in its ability to process and analyze complex medical data, leading to earlier and more accurate diagnoses.87,88 The integration of AI with next-generation sequencing and genomics is also anticipated to advance personalized medicine, enabling treatments tailored specifically to individual genetic profiles.89 Additionally, ongoing innovations in AI could soon enable real-time diagnostics during patient examinations, significantly reducing the wait times for results.90 This capability could transform emergency medicine by providing immediate insights that are critical in acute cases.38

The Role of AI in Shaping the Future of Healthcare Delivery

AI’s impact on healthcare delivery is transformative, offering substantial improvements in efficiency and patient outcomes.37 By automating routine tasks, AI allows healthcare professionals to focus more on patient care rather than administrative duties.91 AI is also expected to play a critical role in managing healthcare resources, optimizing treatment plans, and reducing operational costs.92 As AI systems become more sophisticated, they will aid in real-time decision-making and long-term healthcare planning, potentially leading to a more proactive and preventive healthcare environment.93 Additionally, the integration of AI into telemedicine is enhancing accessibility, allowing patients in remote areas to receive expert diagnostics and monitoring without the need for physical travel.37,42 AI-driven predictive analytics are also being used to forecast patient admissions and manage hospital capacity effectively, ensuring resources are allocated efficiently to meet demand.62,66

Challenges and Opportunities for Integration into Mainstream Medical Practice

Integrating AI into mainstream medical practice presents both challenges and opportunities. One of the primary hurdles is ensuring the ethical use of AI, particularly concerning patient data privacy71 and the potential biases in AI algorithms.94 However, these challenges also present opportunities for improvement, such as developing more robust ethical guidelines and creating AI systems that are transparent and accountable.73 Moreover, the ongoing collaboration between engineers, clinicians, and policymakers is crucial to address these issues and harness AI’s full potential in enhancing healthcare delivery.95 Further challenges include the need for comprehensive training for medical staff to adapt to AI technologies and the integration of AI tools into existing healthcare IT systems without disrupting workflow. Nevertheless, these challenges are met with the opportunity to significantly enhance diagnostic accuracy, reduce healthcare costs, and improve patient outcomes on a large scale.

Conclusion

The exploration of AI in diagnostic medicine reveals profound advancements and transformative potential. AI’s application across various medical specialties, particularly in diagnostics, demonstrates enhanced accuracy and efficiency in analyzing complex data sets. This has led to earlier detection of diseases, personalized treatment plans, and a shift towards more predictive and preventive medical practices. AI’s integration into healthcare promises significant improvements in patient outcomes by automating routine tasks, reducing diagnostic errors, and allowing healthcare professionals to concentrate more on patient care rather than administrative duties. Moreover, the capability of AI to manage and optimize healthcare resources underscores its potential to reshape the future of healthcare delivery, making it more efficient and cost-effective. Furthermore, the economic and global impacts of AI are becoming increasingly significant, as its integration into diagnostic medicine not only streamlines healthcare processes but also promotes substantial economic benefits and greater accessibility across global regions. This evolution is contributing to a reshaping of healthcare systems worldwide, facilitating more equitable access to high-quality medical care and fostering global health equity.

However, the journey towards full integration of AI into mainstream medical practice is not without challenges. Ethical concerns, particularly regarding data privacy and potential biases in AI algorithms, remain at the forefront of discussions. The need for robust ethical guidelines and transparent, accountable AI systems is critical to addressing these issues. Additionally, the technical and practical challenges of implementing AI in diverse healthcare settings require ongoing collaboration among engineers, clinicians, and policymakers. In conclusion, while AI in diagnostic medicine presents a horizon rich with potential, navigating its complexities will require thoughtful management of the ethical, practical, and technical challenges. The continued evolution of AI technology, backed by responsible practices and interdisciplinary cooperation, will be crucial in realizing its full potential to revolutionize diagnostic medicine.

References

1 Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJ. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18(8):500-10.
https://doi.org/10.1038/s41568-018-0016-5
 
2 Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Human Comput. 2023;14(7):8459-86.
https://doi.org/10.1007/s12652-021-03612-z
 
3 Kaur S, Singla J, Nkenyereye L, Jha S, Prashar D, Joshi GP,
 
et al. Medical diagnostic systems using artificial intelligence (AI) algorithms: principles and perspectives. IEEE Access. 2020;8:228049-69.
https://doi.org/10.1109/ACCESS.2020.3042273
 
4 Najjar R. Redefining radiology: a review of artificial intelligence integration in medical imaging. Diagnostics. 2023;13(17):2760.
https://doi.org/10.3390/diagnostics13172760
 
5 Ranschaert E, Topff L, Pianykh O. Optimization of radiology workflow with artificial intelligence. Radiol Clin. 2021;59(6):955-66.
https://doi.org/10.1016/j.rcl.2021.06.006
 
6 Kapoor N, Lacson R, Khorasani R. Workflow applications of artificial intelligence in radiology and an overview of available tools. J Am Coll Radiol. 2020;17(11):1363-70.
https://doi.org/10.1016/j.jacr.2020.08.016
 
7 Cacciamani GE, Sanford DI, Chu TN, Kaneko M, Abreu AL, Duddalwar V, et al. Is artificial intelligence replacing our radiology stars? Not yet!. Eur Urol Open Sci. 2023;48:14-6.
https://doi.org/10.1016/j.euros.2022.09.024
 
8 Khalifa M, Albadawy M. AI in diagnostic imaging: revolutionising accuracy and efficiency. Comput Methods Prog Biomed Update. 2024;5(17):100146.
https://doi.org/10.1016/j.cmpbup.2024.100146
 
9 Tran WT, Sadeghi-Naini A, Lu FI, Gandhi S, Meti N, Brackstone M, et al. Computational radiology in breast cancer screening and diagnosis using artificial intelligence. Can Assoc Radiol J. 2021;72(1):98-108.
https://doi.org/10.1177/0846537120949974
 
10 Uzun Ozsahin D, Ikechukwu Emegano D, Uzun B, Ozsahin I. The systematic review of artificial intelligence applications in breast cancer diagnosis. Diagnostics. 2022;13(1):45.
https://doi.org/10.3390/diagnostics13010045
 
11 Raghavendra U, Acharya UR, Adeli H. Artificial intelligence techniques for automated diagnosis of neurological disorders. Eur Neurol. 2020;82(1-3):41-64.
https://doi.org/10.1159/000504292
 
12 Patel UK, Anwar A, Saleem S, Malik P, Rasul B, Patel K, et al. Artificial intelligence as an emerging technology in the current care of neurological disorders. J Neurol. 2021;268:1623-42.
https://doi.org/10.1007/s00415-019-09518-3
 
13 Niazi MK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence. Lancet Oncol. 2019;20(5):e253-61.
https://doi.org/10.1016/S1470-2045(19)30154-8
 
14 Ahmad Z, Rahim S, Zubair M, Abdul-Ghafar J. Artificial intelligence (AI) in medicine, current applications and future role with special emphasis on its potential and promise in pathology: Present and future impact, obstacles including costs and acceptance among pathologists, practical and philosophical considerations. A comprehensive review. Diagn Pathol. 2021;16:1-6.
https://doi.org/10.1186/s13000-021-01085-4
 
15 Montalto MC. Realizing the promise of tumor infiltrating lymphocytes as a new biomarker for personalized medicine may require the power and precision of artificial intelligence. AI Precis Oncol. 2024;1(1):30-2.
https://doi.org/10.1089/aipo.2023.0003
 
16 Kim I, Kang K, Song Y, Kim TJ. Application of artificial intelligence in pathology: Trends and challenges. Diagnostics. 2022;12(11):2794.
https://doi.org/10.3390/diagnostics12112794
 
17 Hijazi A, Bifulco C, Baldin P, Galon J. Digital pathology for better clinical practice. Cancers. 2024;16(9):1686.
https://doi.org/10.3390/cancers16091686
 
18 Serag A, Ion-Margineanu A, Qureshi H, McMillan R, Saint Martin MJ, Diamond J, et al. Translational AI and deep learning in diagnostic pathology. Front Med. 2019;6:185.
https://doi.org/10.3389/fmed.2019.00185
 
19 Goyal M, Knackstedt T, Yan S, Hassanpour S. Artificial intelligence-based image classification methods for diagnosis of skin cancer: challenges and opportunities. Comput Biol Med. 2020;127:104065.
https://doi.org/10.1016/j.compbiomed.2020.104065
 
20 Alsaade FW, Aldhyani TH, Al-Adhaileh MH. Developing a recognition system for diagnosing melanoma skin lesions using artificial intelligence algorithms. Comput Math Methods Med. 2021;2021(1):9998379.
https://doi.org/10.1155/2021/9998379
 
21 Du-Harpur X, Watt FM, Luscombe NM, Lynch MD. What is AI? Applications of artificial intelligence to dermatology. Br J Dermatol. 2020;183(3):423-30.
https://doi.org/10.1111/bjd.18880
 
22 Chan S, Reddy V, Myers B, Thibodeaux Q, Brownstone N, Liao W. Machine learning in dermatology: Current applications, opportunities, and limitations. Dermatol Ther. 2020;10:365-86.
https://doi.org/10.1007/s13555-020-00372-0
 
23 Gomolin A, Netchiporouk E, Gniadecki R, Litvinov IV. Artificial intelligence applications in dermatology: Where do we stand?. Front Med. 2020;7:100.
https://doi.org/10.3389/fmed.2020.00100
 
24 Li Z, Liu F, Yang W, Peng S, Zhou J. A survey of convolutional neural networks: Analysis, applications, and prospects. IEEE Trans Neural Netw Learn Syst. 2021;33(12):6999-7019.
https://doi.org/10.1109/TNNLS.2021.3084827
 
25 Anwar SM, Majid M, Qayyum A, Awais M, Alnowami M, Khan MK. Medical image analysis using convolutional neural networks:
 
a review. J Med Syst. 2018;42:1-3.
 
26 Panayides AS, Amini A, Filipovic ND, Sharma A, Tsaftaris SA, Young A, et al. AI in medical imaging informatics: current challenges and future directions. IEEE J Biomed Health Informat. 2020;24(7):1837-57.
https://doi.org/10.1109/JBHI.2020.2991043
 
27 Ahmed Z, Mohamed K, Zeeshan S, Dong X. Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine. Database. 2020;2020:baaa010.
https://doi.org/10.1093/database/baaa010
 
28 Bagheri AB, Rouzi MD, Koohbanani NA, Mahoor MH, Finco MG, Lee M, et al. Potential applications of artificial intelligence and machine learning on diagnosis, treatment, and outcome prediction to address health care disparities of chronic limb-threatening ischemia. In: Seminars in Vascular Surgery 2023. WB Saunders.
https://doi.org/10.1053/j.semvascsurg.2023.06.003
 
29 Ibrahim MS, Saber S. Machine learning and predictive analytics: advancing disease prevention in healthcare. J Contemp Healthc Anal. 2023;7(1):53-71.
 
30 Barrett M, Boyne J, Brandts J, Brunner-La Rocca HP, De Maesschalck L, De Wit K, et al. Artificial intelligence supported patient self-care in chronic heart failure: A paradigm shift from reactive to predictive, preventive and personalised care. EPMA J. 2019;10:445-64.
https://doi.org/10.1007/s13167-019-00188-9
 
31 Subramanian M, Wojtusciszyn A, Favre L, Boughorbel S, Shan J, Letaief KB, et al. Precision medicine in the era of artificial intelligence: Implications in chronic disease management. J Transl Med. 2020;18:1-2.
https://doi.org/10.1186/s12967-020-02658-5
 
32 Guan Z, Li H, Liu R, Cai C, Liu Y, Li J, et al. Artificial intelligence in diabetes management: Advancements, opportunities, and challenges. Cell Rep Med. 2023;4(10):101213.
https://doi.org/10.1016/j.xcrm.2023.101213
 
33 Siontis KC, Noseworthy PA, Attia ZI, Friedman PA. Artificial intelligence-enhanced electrocardiography in cardiovascular disease management. Nat Rev Cardiol. 2021;18(7):465-78.
https://doi.org/10.1038/s41569-020-00503-2
 
34 Krittanawong C, Zhang H, Wang Z, Aydar M, Kitai T. Artificial intelligence in precision cardiovascular medicine. J Am Coll Cardiol. 2017;69(21):2657-64.
https://doi.org/10.1016/j.jacc.2017.03.571
 
35 Chintala S. AI-driven personalised treatment plans: The future of precision medicine. Mach Intell Res. 2023;17(02):9718-28.
 
36 Schork NJ. Artificial intelligence and personalized medicine. Precis Med Cancer Ther. 2019:265-83.
https://doi.org/10.1007/978-3-030-16391-4_11
 
37 Prabhod KJ. The role of artificial intelligence in reducing healthcare costs and improving operational efficiency. Q J Emerg Technol Innov. 2024;9(2):47-59.
 
38 Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. Revolutionizing healthcare: The role of artificial intelligence in clinical practice. BMC Med Educ. 2023;23(1):689.
https://doi.org/10.1186/s12909-023-04698-z
 
39 Lee D, Yoon SN. Application of artificial intelligence-based technologies in the healthcare industry: opportunities and challenges. Int J Environ Res Public Health. 2021;18(1):271.
https://doi.org/10.3390/ijerph18010271
 
40 Dash S, Shakyawar SK, Sharma M, Kaushik S. Big data in healthcare: Management, analysis and future prospects. J Big Data. 2019;6(1):1-25.
https://doi.org/10.1186/s40537-019-0217-0
 
41 Lehne M, Sass J, Essenwanger A, Schepers J, Thun S. Why digital medicine depends on interoperability. NPJ Digit Med. 2019;2(1):79.
https://doi.org/10.1038/s41746-019-0158-1
 
42 Pillai AS. AI-enabled hospital management systems for modern healthcare: an analysis of system components and interdependencies. J Adv Anal Healthcare Manag. 2023;7(1):212-28.
 
43 Aminizadeh S, Heidari A, Dehghan M, Toumaj S, Rezaei M, Navimipour NJ. Opportunities and challenges of artificial intelligence and distributed systems to improve the quality of healthcare service. Artif Intell Med. 2024;149:102779.
https://doi.org/10.1016/j.artmed.2024.102779
 
44 Khanna NN, Maindarkar MA, Viswanathan V, Fernandes JF, Paul S, Bhagawati M, et al. Economics of artificial intelligence in healthcare: Diagnosis vs. treatment. In: Healthcare 2022 (Vol. 10, No. 12, p. 2493). MDPI.
https://doi.org/10.3390/healthcare10122493
 
45 Diallo A. AI-driven diagnostic tools for early detection of chronic diseases: Leveraging machine learning for enhancing accuracy and speed of diagnostic procedures. J Bioinformat Artif Intell. 2023;3(2):213-36.
 
46 Hurvitz N, Azmanov H, Kesler A, Ilan Y. Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. Eur J Human Genet. 2021;29(10):1485-90.
https://doi.org/10.1038/s41431-021-00928-4
 
47 MarketsandMarkets Research. Artificial Intelligence (AI) in Healthcare Market Size, Share & Growth 2024. https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html?srsltid=AfmBOopBInkezo-39nCiUPEEQcpE8M_C52d62Tt0nXxqDFmJzTEAPLV.
 
48 Mrazek M, O’Neill F. Artificial Intelligence and Healthcare in Emerging Markets. International Finance Corporation, World Bank Group 2020. https://www.ifc.org/content/dam/ifc/doc/mgrt/emcompass-note-91-healthcare-and-ai-fin-sept- web.pdf
 
49 Chatterjee S. AI strategy of India: Policy framework, adoption challenges and actions for government. Transform Gov People Process Policy. 2020;14(5):757-75.
https://doi.org/10.1108/TG-05-2019-0031
 
50 Kong X, Ai B, Kong Y, Su L, Ning Y, Howard N, et al. Artificial intelligence: A key to relieve China’s insufficient and unequally-distributed medical resources. Am J Transl Res. 2019;11(5):2632.
 
51 Begum S, Paul S. AI in healthcare and economic growth: A comparative analysis of developed and emerging economies. In: Opportunities and Risks in AI for Business Development 2024 (Vol. 2, pp. 595-610). Springer Nature Switzerland.
https://doi.org/10.1007/978-3-031-65207-3_51
 
52 Rajendran S, Porwal A, Anjali K, Anvaya, Anuradha RJ. Portable IoT devices in healthcare for health monitoring and diagnostics. In: Internet of Things in Bioelectronics: Emerging Technologies and Applications 2024 (pp. 263-96).
https://doi.org/10.1002/9781394241903.ch13
 
53 Oladipo EK, Adeyemo SF, Oluwasanya GJ, Oyinloye OR, Oyeyiola OH, Akinrinmade ID, et al. Impact and challenges of artificial intelligence integration in the African health sector: A review. Trends Med Res. 2024;19(1):220-35.
https://doi.org/10.3923/tmr.2024.220.235
 
54 Liang F, Yang X, Peng W, Zhen S, Cao W, Li Q, et al. Applications of digital health approaches for cardiometabolic diseases prevention and management in the Western Pacific region. Lancet Reg Health West Pac. 2024;43:100817.
https://doi.org/10.1016/j.lanwpc.2023.100817
 
55 da Silva Motta D, Badaró R, Santos A, Kirchner F. Use of artificial intelligence on the control of vector-borne diseases. In: Vectors and Vector-Borne Zoonotic Diseases 2019 (p. 107).
https://doi.org/10.5772/intechopen.81671
 
56 Saran S, Singh P. Systematic review on citizen science and artificial intelligence for vector-borne diseases. Int Arch Photogram Remote Sens Spatial Inf Sci. 2024;48:397-402.
https://doi.org/10.5194/isprs-archives-XLVIII-4-2024-397-2024
 
57 Asif S, Wenhui Y, ur-Rehman S, ul-ain Q, Amjad K, Yueyang Y,
 
et al. Advancements and prospects of machine learning in medical diagnostics: Unveiling the future of diagnostic precision. Arch Comput Methods Eng. 2024:1-31.
 
58 Bohr A, Memarzadeh K. The rise of artificial intelligence in healthcare applications. In: Artificial Intelligence in Healthcare 2020 (pp. 25-60). Academic Press.
https://doi.org/10.1016/B978-0-12-818438-7.00002-2
 
59 Lopez-Jimenez F, Attia Z, Arruda-Olson AM, Carter R, Chareonthaitawee P, Jouni H, et al. Artificial intelligence in cardiology: Present and future. In: Mayo Clinic Proceedings 2020 (Vol. 95, No. 5, pp. 1015-39). Elsevier.
https://doi.org/10.1016/j.mayocp.2020.01.038
 
60 Soun JE, Chow DS, Nagamine M, Takhtawala RS, Filippi CG, Yu W,
 
et al. Artificial intelligence and acute stroke imaging. Am J Neuroradiol. 2021;42(1):2-11.
https://doi.org/10.3174/ajnr.A6883
 
61 Roy S. Privacy prevention of health care data using AI. J Data Acquis Process. 2022;37(3):769.
 
62 Messinis S, Temenos N, Protonotarios NE, Rallis I, Kalogeras D, Doulamis N. Enhancing internet of medical things security with artificial intelligence: A comprehensive review. Comput Biol Med. 2024;170:108036.
https://doi.org/10.1016/j.compbiomed.2024.108036
 
63 Ho CW, Soon D, Caals K, Kapur J. Governance of automated image analysis and artificial intelligence analytics in healthcare. Clin Radiol. 2019;74(5):329-37.
https://doi.org/10.1016/j.crad.2019.02.005
 
64 Ellahham S, Ellahham N, Simsekler MC. Application of artificial intelligence in the health care safety context: opportunities and challenges. Am J Med Q. 2020;35(4):341-8.
https://doi.org/10.1177/1062860619878515
 
65 Seyyed-Kalantari L, Zhang H, McDermott MB, Chen IY, Ghassemi M. Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations. Nat Med. 2021;27(12):2176-82.
https://doi.org/10.1038/s41591-021-01595-0
 
66 Zhang J, Zhang ZM. Ethics and governance of trustworthy medical artificial intelligence. BMC Med Inform Decis Mak. 2023;23(1):7.
https://doi.org/10.1186/s12911-023-02103-9
 
67 Stanley EA, Wilms M, Forkert ND. Disproportionate subgroup impacts and other challenges of fairness in artificial intelligence for medical image analysis. In: Workshop on the Ethical and Philosophical Issues in Medical Imaging 2022 (pp. 14-25). Springer Nature Switzerland.
https://doi.org/10.1007/978-3-031-23223-7_2
 
68 Jain A, Brooks JR, Alford CC, Chang CS, Mueller NM, Umscheid CA, et al. Awareness of racial and ethnic bias and potential solutions to address bias with use of health care algorithms. In: JAMA Health Forum 2023 (Vol. 4, No. 6, p. e231197). American Medical Association.
https://doi.org/10.1001/jamahealthforum.2023.1197
 
69 Khanna S, Srivastava S, Khanna I, Pandey V. Ethical challenges arising from the integration of artificial intelligence (AI) in oncological management. Int J Res Artif Intell. 2020;10(8):
 
34-44.
 
70 Koçak B, Ponsiglione A, Stanzione A, Bluethgen C, Santinha J, Ugga L, et al. Bias in artificial intelligence for medical imaging: Fundamentals, detection, avoidance, mitigation, challenges, ethics, and prospects. Diagn Interv Radiol. 2024.
https://doi.org/10.4274/dir.2024.242854
 
71 Challen R, Denny J, Pitt M, Gompels L, Edwards T, Tsaneva-Atanasova K. Artificial intelligence, bias and clinical safety. BMJ Q Saf. 2019;28(3):231-7.
https://doi.org/10.1136/bmjqs-2018-008370
 
72 World Health Organization. Ethics and Governance of Artificial Intelligence for Health: Guidance on Large Multi-modal Models 2024. https://www.who.int/publications/i/item/9789240084759
 
73 Chen Y, Clayton EW, Novak LL, Anders S, Malin B. Human-centered design to address biases in artificial intelligence. J Med Int Res. 2023;25:e43251.
https://doi.org/10.2196/43251
 
74 Ursin F, Timmermann C, Orzechowski M, Steger F. Diagnosing diabetic retinopathy with artificial intelligence: What information should be included to ensure ethical informed consent?. Front Med. 2021;8:695217.
https://doi.org/10.3389/fmed.2021.695217
 
75 Cohen IG. Informed consent and medical artificial intelligence: What to tell the patient?. Geo LJ. 2019;108:1425.
https://doi.org/10.2139/ssrn.3529576
 
76 Khanna S, Srivastava S. Patient-centric ethical frameworks for privacy, transparency, and bias awareness in deep learning-based medical systems. Appl Res Artif Intell Cloud Comput. 2020;3(1):16-35.
 
77 Moawad AW, Fuentes DT, ElBanan MG, Shalaby AS, Guccione J, Kamel S, et al. Artificial intelligence in diagnostic radiology: where do we stand, challenges, and opportunities. J Comput Assist Tomogr. 2022;46(1):78-90.
https://doi.org/10.1097/RCT.0000000000001247
 
78 Ting DS, Pasquale LR, Peng L, Campbell JP, Lee AY, Raman R,
 
et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167-75.
https://doi.org/10.1136/bjophthalmol-2018-313173
 
79 Huang X, Wang H, She C, Feng J, Liu X, Hu X, et al. Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy. Front Endocrinol. 2022;13:946915.
https://doi.org/10.3389/fendo.2022.946915
 
80 Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunović H. Artificial intelligence in retina. Prog Retin Eye Res. 2018;67:1-29.
https://doi.org/10.1016/j.preteyeres.2018.07.004
 
81 Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44-56.
https://doi.org/10.1038/s41591-018-0300-7
 
82 Shen J, Zhang CJ, Jiang B, Chen J, Song J, Liu Z, et al. Artificial intelligence versus clinicians in disease diagnosis: systematic review. JMIR Med Inform. 2019;7(3):e10010.
https://doi.org/10.2196/10010
 
83 Faqar-Uz-Zaman SF, Anantharajah L, Baumartz P, Sobotta P, Filmann N, Zmuc D, et al. The diagnostic efficacy of an app-based diagnostic health care application in the emergency room: eRadaR-trial. A prospective, double-blinded, observational study. Ann Surg. 2022;276(5):935-42.
https://doi.org/10.1097/SLA.0000000000005614
 
84 Sai S, Gaur A, Sai R, Chamola V, Guizani M, Rodrigues JJ. Generative ai for transformative healthcare: a comprehensive study of emerging models, applications, case studies and limitations. IEEE Access. 2024.
https://doi.org/10.1109/ACCESS.2024.3367715
 
85 Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17:1-9.
https://doi.org/10.1186/s12916-019-1426-2
 
86 Feng J, Phillips RV, Malenica I, Bishara A, Hubbard AE, Celi LA,
 
et al. Clinical artificial intelligence quality improvement: Towards continual monitoring and updating of AI algorithms in healthcare. NPJ Digit Med. 2022;5(1):66.
https://doi.org/10.1038/s41746-022-00611-y
 
87 Xu J, Yang P, Xue S, Sharma B, Sanchez-Martin M, Wang F, et al. Translating cancer genomics into precision medicine with artificial intelligence: Applications, challenges and future perspectives. Hum Genet. 2019;138(2):109-24.
https://doi.org/10.1007/s00439-019-01970-5
 
88 Li X, Tian D, Li W, Dong B, Wang H, Yuan J, et al. Artificial intelligence-assisted reduction in patients’ waiting time for outpatient process: a retrospective cohort study. BMC Health Serv Res. 2021;21:1.
https://doi.org/10.1186/s12913-021-06248-z
 
89 Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545-6.
https://doi.org/10.1001/jama.2020.4031
 
90 Patil S, Shankar H. Transforming healthcare: harnessing the power of AI in the modern era. Int J Multidiscip Sci Arts. 2023;2(1):60-70.
https://doi.org/10.47709/ijmdsa.v2i1.2513
 
91 Galil A, Galil WA. Applications of artificial intelligence in the field of diagnostic medicine and future prospects. Int J Artif Intell Emerg Technol. 2023;6(2):1-8.
https://doi.org/10.21608/ijaiet.2024.275176.1005
 
92 Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int. 2021;2:100117.
https://doi.org/10.1016/j.sintl.2021.100117
 
93 Chintala S. Improving healthcare accessibility with AI-enabled telemedicine solutions. Int J Res Rev Tech. 2023;2(1):75-81.
 
94 Chauhan C, Gullapalli RR. Ethics of AI in pathology: current paradigms and emerging issues. Am J Pathol. 2021;191(10):1673-83.
https://doi.org/10.1016/j.ajpath.2021.06.011
 
95 Paranjape K, Schinkel M, Panday RN, Car J, Nanayakkara P. Introducing artificial intelligence training in medical education. JMIR Med Educ. 2019;5(2):e16048.
https://doi.org/10.2196/16048